Cargando…
Checkpoint inhibitors, fertility, pregnancy, and sexual life: a systematic review
Immune checkpoint inhibitors (i.e. anti-PD1, anti-PDL1, and anti-CTLA4) have revolutionized the therapeutic approach of several cancer types. In a subset of metastatic patients, the duration of the response is so long that a cure might be hypothesized, and a treatment discontinuation strategy could...
Autores principales: | Garutti, M., Lambertini, M., Puglisi, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487000/ https://www.ncbi.nlm.nih.gov/pubmed/34597942 http://dx.doi.org/10.1016/j.esmoop.2021.100276 |
Ejemplares similares
-
Corrigendum to ‘Checkpoint inhibitors, fertility, pregnancy, and sexual life: a systematic review’: [ESMO Open Volume 6, Issue 5, October 2021, 100276]
por: Garutti, M., et al.
Publicado: (2021) -
Influenza vaccination in cancer patients receiving immune checkpoint inhibitors: A systematic review
por: Spagnolo, Francesco, et al.
Publicado: (2021) -
The effect of paternal exposure to immunosuppressive drugs on sexual function, reproductive hormones, fertility, pregnancy and offspring outcomes: a systematic review
por: Perez-Garcia, L F, et al.
Publicado: (2020) -
Immune checkpoint inhibitor administration during pregnancy: a case series
por: Andrikopoulou, A., et al.
Publicado: (2021) -
Fertility disorders and pregnancy complications in hairdressers - a systematic review
por: Peters, Claudia, et al.
Publicado: (2010)